Early and late outcomes after aortic valve replacement, mitral valve replacement and mitral valve plasty for native and prosthetic valve endocarditis in The Netherlands
Rattachement africain : nl. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Aims: The aim of this nationwide descriptive study is to assess short-, mid-, and long-term mortality risk following aortic valve replacement (AVR), mitral valve replacement (MVR) and mitral valve plasty (MVP) in patients with native valve endocarditis (NVE) and prosthetic valve endocarditis (PVE). Mortality outcomes were also evaluated for biological and mechanical valve prostheses. Methods and results: Patients with infective endocarditis who underwent AVR, MVR, or MVP between 2013 and 2022 were included from the Netherlands Heart Registration. Patients were excluded in case of combined valve surgery, aortic root replacement, a history of non-valvular cardiac surgery followed by NVE and unclear surgical history precluding confirmation of PVE. Descriptive analyses were performed, and mortality risks were estimated using Kaplan-Meier analysis. 1810 patients were included, of whom 75.4% had NVE and 24.6% PVE. In NVE, short-term mortality was highest after MVR (13.2%), followed by AVR (4.6%) and MVP (3.8%). Long-term mortality risks were 32.1%, 22.3%, and 11.5%, respectively. In PVE, short-term mortality risk was highest in AVR (10.2%), followed by MVR (7.6%) and MVP (5.0%). Long-term mortality risks were 27.3%, 31.7% and 35.2%, respectively. Short-term mortality was similar between patients receiving biological and mechanical prosthesis in the AVR and MVR groups, whereas long-term mortality was higher among those who received biological prostheses. Conclusion: This nationwide study shows that mortality after cardiac surgery for infective endocarditis considerably varies by valve and prosthesis type. In NVE, mortality was highest after MVR. In PVE, outcomes were comparable across procedures. Long-term mortality was lowest with mechanical prostheses.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Early and late outcomes after aortic valve replacement, mitral valve replacement and mitral valve plasty for native and prosthetic valve endocarditis in The Netherlands
- Date Crossref
- 01/01/2026
- Éditeur
- Oxford University Press (OUP)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Haga Hospital pays non établi dans la noticeÉtablissement de santé
-
Amsterdam University Medical Centers Department of Cardiology pays non établi dans la noticeÉtablissement de santé
-
Leiden University Medical Center Department of Clinical Epidemiology pays non établi dans la noticeOrganisme public
-
Utrecht University Department of Cardiology pays non établi dans la noticeUniversité ou école supérieure
-
University Medical Center Utrecht pays non établi dans la noticeÉtablissement de santé
-
St. Antonius Ziekenhuis pays non établi dans la noticeOrganisme public
-
Netherlands Heart Registration pays non établi dans la noticeOrganisation à but non lucratif
-
University of Amsterdam pays non établi dans la noticeUniversité ou école supérieure
-
Haga Teaching Hospital Department of Cardiology pays non établi dans la noticeÉtablissement de santé
-
St.Antonius Hospital Department of Cardiology pays non établi dans la noticeÉtablissement de santé
Haga Hospital, Department of Cardiology — Amsterdam University Medical Centers et Department of Clinical Epidemiology — Leiden University Medical Center, avec 7 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.